The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Mineralys Therapeutics Inc shares valued at $3,499,996 were purchased by Slingsby Brian Taylor on Mar 13 ’25. At $13.50 per share, Slingsby Brian Taylor acquired 259,259 shares. The insider’s holdings grew to 8,903,838 shares worth approximately $126.52 million following the completion of this transaction.
Also, Rodman David Malcom sold 11,366 shares, netting a total of over 165,185 in proceeds. Following the sale of shares at $14.53 each, the insider now holds 111,686 shares.
Before that, Levy Adam Scott had sold 10,757 shares from its account. In a trade valued at $129,684, the CFO and Secretary traded Mineralys Therapeutics Inc shares for $12.06 each. Upon closing the transaction, the insider’s holdings decreased to 10,757 shares, worth approximately $3.06 million.
As published in their initiating research note from H.C. Wainwright on July 10, 2024, Mineralys Therapeutics Inc [MLYS] has been a Buy and the price target has been revised to $30. Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in early April. As of March 07, 2023, Wells Fargo has initiated its “an Overweight” rating for MLYS. Earlier on March 07, 2023, Stifel initiated its rating. Their recommendation was “a Buy” for MLYS stock.
Analyzing MLYS Stock Performance
During the last five days, there has been a surge of approximately 5.03%. Over the course of the year, Mineralys Therapeutics Inc shares have jumped approximately 15.43%. Shares of the company reached a 52-week high of $18.38 on 03/19/25 and a 52-week low of $8.24 on 02/25/25. A 50-day SMA is recorded $12.99, while a 200-day SMA reached $12.33.
Support And Resistance Levels for Mineralys Therapeutics Inc (MLYS)
According to the 24-hour chart, there is a support level at 13.80, which, if violated, would cause prices to drop to 13.38. In the upper region, resistance lies at 14.55. The next price resistance is at 14.89. RSI (Relative Strength Index) is 55.24 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.38, which suggests the price will decrease in the coming days. Percent R is at 18.51%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
